BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 7474938)

  • 1. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
    Dodge GR; Boesler EW; Jimenez SA
    Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
    Larraín J; Alvarez J; Hassell JR; Brandan E
    Exp Cell Res; 1997 Aug; 234(2):405-12. PubMed ID: 9260911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
    Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
    J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture.
    Rescan PY; Loréal O; Hassell JR; Yamada Y; Guillouzo A; Clément B
    Am J Pathol; 1993 Jan; 142(1):199-208. PubMed ID: 7678718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation.
    Smith SE; French MM; Julian J; Paria BC; Dey SK; Carson DD
    Dev Biol; 1997 Apr; 184(1):38-47. PubMed ID: 9142982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of perlecan proteoglycan in metastatic melanomas.
    Cohen IR; Murdoch AD; Naso MF; Marchetti D; Berd D; Iozzo RV
    Cancer Res; 1994 Nov; 54(22):5771-4. PubMed ID: 7954396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.
    Mathiak M; Yenisey C; Grant DS; Sharma B; Iozzo RV
    Cancer Res; 1997 Jun; 57(11):2130-6. PubMed ID: 9187109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
    Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
    Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin.
    Gauer S; Schulze-Lohoff E; Schleicher E; Sterzel RB
    Eur J Cell Biol; 1996 Jul; 70(3):233-42. PubMed ID: 8832207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
    Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
    Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
    Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
    Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart.
    Asundi VK; Keister BF; Stahl RC; Carey DJ
    Exp Cell Res; 1997 Jan; 230(1):145-53. PubMed ID: 9013716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perlecan gene expression precedes laminin gene expression during differentiation of F9 embryonal carcinoma cells.
    Chakravarti S; Hassell JR; Phillips SL
    Dev Dyn; 1993 Jun; 197(2):107-14. PubMed ID: 8219353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
    Graham LD; Whitelock JM; Underwood PA
    Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycan expression in normal human liver.
    Roskams T; Moshage H; De Vos R; Guido D; Yap P; Desmet V
    Hepatology; 1995 Apr; 21(4):950-8. PubMed ID: 7705805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
    Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
    Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S; Stahl RC; Carey DJ; Bansal R
    J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.